LT - Kristalinė (S)-N-(5-((R)-2-(2,5-difluorfenil)-pirolidin-1-il)-pirazolo[1,5-a] pirimidin-3-il)-3 -hidroksipirolidino-1-karboksamido vandenilio sulfato forma
EN - CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07D 487/04 |
(2006.01) |
|
|
A61K 31/519 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
(11) |
Number of the document |
3699181 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
20169707.5 |
|
Date of filing the European patent application |
2015-11-16 |
(97) |
Date of publication of the European application |
2020-08-26 |
(45) |
Date of publication and mention of the grant of the patent |
2023-03-01
|
(46) |
Date of publication of the claims translation |
2023-05-10
|
Priority applications
(30) |
Number |
Date |
Country code |
|
201462080374 P |
2014-11-16
|
US |
|
201562169545 P |
2015-06-01
|
US |
Inventors
(72) |
ARRIGO, Alisha B. , US
JUENGST, Derrick , US
SHAH, Khalid , US
|
Grantee
(73) |
Array Biopharma, Inc. ,
3200 Walnut Street, Boulder, CO 80301,
US
|
Attorney or representative
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
(54) |
Kristalinė (S)-N-(5-((R)-2-(2,5-difluorfenil)-pirolidin-1-il)-pirazolo[1,5-a] pirimidin-3-il)-3 -hidroksipirolidino-1-karboksamido vandenilio sulfato forma |
|
CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-09-26 |
11 |
289.00
EUR
|
Next renewal fee
|
2026-11-16 |